A RECOMBINANT ADENOVIRUS RELATING GENE VACCINE USED TO THERAPY AND PREVENT ALZHEIMERS DISEASE, AND USE THEREOF

Details for Australian Patent Application No. 2003289631 (hide)

International Classifications

Event Publications

8 April 2004 Complete Application Filed

Priority application(s): 02154703.3 29.11.02 CN

29 July 2004 Application Open to Public Inspection

Published as AU-A-2003289631

18 August 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

1 September 2005 Corrigenda

Applications OPI - Name Index Under the name AGTC GENE TECHNOLOGY COMPANY LTD., Application No. 2003289631, under INID (71) correct the name to read INSTITUTE OF BASIC MEDICAL SCIENCES,CHINESE ACADEMY OF MEDICAL SCIENCES; INSTITUTE OF LABORATORY ANIMALS,CHINESE ACADEMY OF MEDICAL SCIENCES; AGTC GENE TECHNOLOGY COMPANY LTD.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.